{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"EGAX00001379544","attributes":{"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["192"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BSX/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"458M","NAME":"S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160324.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BSX/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160324.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"e6626f055e9674e020447158cd6b9978"},{"FORMAT":"bigBed","SIZE":"849K","NAME":"S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BSX/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"3cfb474510338941738e4a9ca154cf05"},{"FORMAT":"BED","SIZE":"1.1M","NAME":"S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BSX/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"dff96283243cfc059c57d38fbf04e3f3"},{"FORMAT":"Text","SIZE":"1.2M","NAME":"S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BSX/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BSXH1.ERX1384810.H3K4me3.bwa.GRCh38.20160708.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"8021c5bfb5eb5126baf0981df395e2d7"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"S01BSX","sample_barcode":"S01BSXH1","attributes":{"MARKERS":["CD34"],"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["20 - 25"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"BIOMATERIAL_PROVIDER":["Prof.dr. E. Vellenga, University Medical Centre Groningen - Department of Hematology"],"CELL_TYPE":["myeloid cell"],"BIOMATERIAL_TYPE":["Primary Cell"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SAMPLE_ONTOLOGY_URI":[{"url":"3","label":"CL_0000763"}],"GENDER":["female"],"DONOR_ID":["S01BSX"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["Caucasian"]},"SAMPLE_ID":"EGAN00001374923","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}